Funding from BIO-X Accelerate Program

Gradientech has been awarded with SEK 6.3M from the BIO-X Accelerate program. The funding will support the commercialization journey of its diagnostic system QuickMIC®, by advancing the production transfer of the antibiotic panels, and by securing the clinical performance studies.

Link to press-release

MD671011